Presentation: Should neoadjuvant chemotherapy be preferred to an alternative treatment for advanced ovarian cancer: comparison of neoadjuvant chemotherapy followed by interval debulking surgery and primary debulking surgery in patients with advanced ovarian cancer (2015 Annual Meeting on Women's Cancer®)

Working to Eradicate Gynecologic Cancers

439
Should neoadjuvant chemotherapy be preferred to an alternative treatment for advanced ovarian cancer: comparison of neoadjuvant chemotherapy followed by interval debulking surgery and primary debulking surgery in patients with advanced ovarian cancer

Sunday, March 29, 2015: 7:00 AM

Salon C-D (Hilton Chicago)

J. Liu
Cancer Center, Sun Yat-Sen University, Guangzhou, China